N@N

Emmanuel Papadakis Maintained (BNTX) at Strong Buy with Increased Target to $150 on, Sep 19th, 2024

Emmanuel Papadakis of Deutsche Bank, Maintained "BioNTech SE" (BNTX) at Strong Buy with Increased Target from $95 to $150 on, Sep 19th, 2024.

Emmanuel has made no other calls on BNTX in the last 4 months.

There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 3 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Eliana Merle of "UBS" Maintained at Hold with Increased Target to $131 on, Wednesday, September 18th, 2024
• Jessica Fye of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $125 on, Monday, September 16th, 2024
• Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024

These are the ratings of the 3 analyists that currently disagree with Emmanuel

---

• Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $150 on, Tuesday, September 17th, 2024
• Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $113 on, Monday, September 16th, 2024
• Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $150 on, Monday, September 16th, 2024

Contributing Sources

---